Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (<scp>JUNCTURE</scp>)

2014275 citationsJournal Article

Authors

Secukinumab delivered by autoinjector/pen is efficacious, well-tolerated and associated with high usability in moderate to severe plaque psoriasis.

Good health and well-being

Published in: Journal of the European Academy of Dermatology and Venereology

Volume 29, Issue 6, pp. 1082-1090

Field-Weighted Citation Impact: 11.42